MedPath

Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery

Not Applicable
Completed
Conditions
Post Lasik Surgery Inflammation
Interventions
Drug: antibiotic/steroid combination
Registration Number
NCT00330824
Lead Sponsor
Federal University of São Paulo
Brief Summary

Efficacy/Safety of antibiotic steroid combination compared with individual administration in inflammation Post-LASIK

Detailed Description

antibiotic/steroid combination compared to individuals components 15 days of treatment

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • patients having LASIK surgery;
  • men or women of any race, between 18 and 50 years old, presenting up to 8 degrees of myopia or up to 4 degrees of hypermetropia, or up to 3 degrees of astigmatism, without any other associated ocular problems
Exclusion Criteria
  • Uncontrolled glaucoma or intraocular hypertension;
  • Use of any ocular anti-infectious drugs or any topical or systemic ocular NSAIDs during the study but study drugs;
  • A history of chronic or recurrent ocular inflammatory disease;
  • Uncontrolled diabetes mellitus and diabetic retinopathy ;
  • Patients with sight in a single eye;
  • Iris atrophy in the eye to be operated;
  • Pregnant or lactating women, or women of childbearing potential who are not using proper birth-control methods;
  • Known or suspected allergy or hypersensitivity to any component of study medication;
  • A history or any other evidence of severe systemic disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
antibiotic steroid (single vial)antibiotic/steroid combinationefficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery
antibiotic / steroid (2 vials)moxifloxacin/dexamethasoneefficacy of antibiotic steroid combination compared with individual administration in prevention of postoperative inflammation in patients having LASIK surgery
Primary Outcome Measures
NameTimeMethod
day 15 evaluation of anterior chamber15 days pos-op
Secondary Outcome Measures
NameTimeMethod
day 15 evaluation of ocular pain, physician´s follow-up impression of inflammatory reaction score15 days pos-op

Trial Locations

Locations (1)

Dept. of Ophthalmology - Rua Botucatu 824

🇧🇷

São paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath